Immune Health

Best Peptides for Autoimmune Disease: Evidence-Based Guide

Guide to peptides for autoimmune disease — thymosin alpha-1, BPC-157, and low-dose naltrexone with evidence, dosing, and immune modulation protocols.

Autoimmune diseases collectively affect 5-8% of the population; over 80 distinct conditions

This page is for educational purposes only and does not constitute medical advice. Peptides discussed are research compounds. Always consult a qualified healthcare provider for diagnosis and treatment.

Understanding Autoimmune Diseases

Autoimmune diseases occur when the immune system attacks the body's own tissues. Common conditions include rheumatoid arthritis, lupus, multiple sclerosis, Hashimoto's thyroiditis, and inflammatory bowel disease. They involve dysregulated T-cell and B-cell activity, inflammatory cytokine overproduction, and loss of immune tolerance.

Common Symptoms

Varies by condition

Chronic inflammation and pain

Fatigue

Organ-specific dysfunction

Flares and remissions

Systemic symptoms (fever, weight loss)

Conventional Treatments

Corticosteroids (acute flares)DMARDs (methotrexate, hydroxychloroquine)Biologics (TNF inhibitors, IL-6 inhibitors)JAK inhibitorsImmunosuppressants (azathioprine, mycophenolate)Disease-specific treatments

How Peptides May Help

Thymosin Alpha-1 modulates immune function by enhancing regulatory T-cell activity and reducing inflammatory cytokine production — potentially restoring immune tolerance. BPC-157 has anti-inflammatory effects and supports gut barrier integrity, which is increasingly linked to autoimmune disease pathogenesis.

Top Peptides for Autoimmune Diseases

1Thymosin Alpha-1

Moderate — clinical data for hepatitis and cancer; limited for autoimmune specifically

Mechanism: Immune modulation, regulatory T-cell enhancement, reduction of inflammatory cytokines

Typical dose: 1.6mg SubQ twice weekly for 6-12 weeks

2BPC-157

Preclinical for autoimmune conditions

Mechanism: Anti-inflammatory, gut barrier support, autonomic nervous system modulation

Typical dose: 250-500mcg oral or SubQ daily

Suggested Starting Protocol

Thymosin Alpha-1 1.6mg SubQ twice weekly for 12 weeks. BPC-157 250mcg oral daily for gut barrier support. These are experimental adjuncts — never discontinue prescribed immunosuppressants or biologics without physician guidance.

Important: Autoimmune diseases require specialist management (rheumatologist, immunologist). Peptides are experimental adjuncts with limited clinical data for most autoimmune conditions. Immune modulation in autoimmune disease is complex — interventions that boost immunity may worsen some conditions. Always work with a specialist.

Frequently Asked Questions

Is Thymosin Alpha-1 safe for autoimmune disease?

Thymosin Alpha-1 is an immune modulator, not an immune stimulator. It enhances regulatory T-cell activity, which may help restore immune tolerance. However, its effects in specific autoimmune conditions are not well-studied — use under specialist supervision.

Can BPC-157 help with inflammatory bowel disease?

BPC-157 has shown anti-inflammatory effects in animal models of IBD. It is one of the more promising peptides for gut-related autoimmune conditions. Human clinical data is limited.

Should I stop my biologics to try peptides?

Absolutely not. Never discontinue prescribed immunosuppressants or biologics without physician guidance. Autoimmune disease flares can be severe. Peptides are experimental adjuncts to be added under medical supervision, not replacements for proven treatments.

Related Conditions

Leaky Gut (Intestinal Permeability)Chronic Fatigue Syndrome (ME/CFS)Depression (Major Depressive Disorder)hormonal imbalance

Find the right peptide for your biology

Take our 5-minute quiz to get a personalized peptide recommendation based on your specific goals and health profile.